Novel treatment protocol targets the deadliest cases of C. difficile infection

A new study from the University of Minnesota Medical School has demonstrated that fecal microbiota transplantation (FMT) can rapidly reverse systemic inflammation and improve survival in patients with fulminant Clostridioides difficile (C. difficile) infection—a life-threatening condition characterized by a sepsis-like state. The findings are published in Clinical Gastroenterology and Hepatology.